Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis.
Berberine (BBR) is a compound originally identified in a Chinese herbal medicine Huanglian (Coptis chinensis French). It improves glucose metabolism in type 2 diabetic patients. The mechanisms involve in activation of adenosine monophosphate activated protein kinase (AMPK) and improvement of insulin...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science (PLoS)
2011-02-01
|
| シリーズ: | PLoS ONE |
| オンライン・アクセス: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0016556&type=printable |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
